Literature DB >> 27327294

Retinal Detachment After Subretinal Stem Cell Transplantation.

Ella H Leung, Harry W Flynn, Thomas A Albini, Carlos A Medina.   

Abstract

A 60-year-old man with Stargardt's macular dystrophy and visual acuity of 20/400 in the right eye and 20/60 in the left eye underwent a subretinal injection of autologous bone marrow-derived stem cells in the right eye. The patient developed a retinal detachment in the right eye 2 months later that was initially treated with a scleral buckle, but the patient subsequently developed a recurrent retinal detachment with proliferative vitreoretinopathy. A pars plana vitrectomy, membrane peel, fluid-air exchange, endolaser, and silicone oil injection were then performed. The retina remained attached 5 months later, with improvement in visual acuity from hand motions to 20/300 post-vitrectomy. Retinal detachment may occur after subretinal injection of stem cells. Proliferative vitreoretinopathy may develop in these patients, but the visual acuity may return to baseline after retinal reattachment. [Ophthalmic Surg Lasers Imaging Retina. 2016;47:600-601.]. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Year:  2016        PMID: 27327294     DOI: 10.3928/23258160-20160601-16

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  9 in total

1.  Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States.

Authors:  Rajinder S Nirwan; Thomas A Albini; Jayanth Sridhar; Harry W Flynn; Ajay E Kuriyan
Journal:  Ophthalmology       Date:  2019-03-21       Impact factor: 12.079

Review 2.  Retinal stem cell transplantation: Balancing safety and potential.

Authors:  Mandeep S Singh; Susanna S Park; Thomas A Albini; M Valeria Canto-Soler; Henry Klassen; Robert E MacLaren; Masayo Takahashi; Aaron Nagiel; Steven D Schwartz; Kapil Bharti
Journal:  Prog Retin Eye Res       Date:  2019-09-05       Impact factor: 21.198

3.  Unproven stem cell therapy for macular degeneration.

Authors:  Zubair A Ansari; Ajay E Kuriyan; Thomas A Albini
Journal:  Oncotarget       Date:  2017-10-19

4.  Human Umbilical Tissue-Derived Cells Secrete Soluble VEGFR1 and Inhibit Choroidal Neovascularization.

Authors:  Jing Cao; Rong Yang; Taylor E Smith; Stephanie Evans; Gary W McCollum; Steven C Pomerantz; Theodore Petley; Ian R Harris; John S Penn
Journal:  Mol Ther Methods Clin Dev       Date:  2019-05-22       Impact factor: 6.698

Review 5.  Enduring Neuroprotective Effect of Subacute Neural Stem Cell Transplantation After Penetrating TBI.

Authors:  Anelia A Y Kassi; Anil K Mahavadi; Angelica Clavijo; Daniela Caliz; Stephanie W Lee; Aminul I Ahmed; Shoji Yokobori; Zhen Hu; Markus S Spurlock; Joseph M Wasserman; Karla N Rivera; Samuel Nodal; Henry R Powell; Long Di; Rolando Torres; Lai Yee Leung; Andres Mariano Rubiano; Ross M Bullock; Shyam Gajavelli
Journal:  Front Neurol       Date:  2019-01-17       Impact factor: 4.086

Review 6.  Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment.

Authors:  Yu Lin; Xiang Ren; Yongjiang Chen; Danian Chen
Journal:  Front Neurosci       Date:  2021-01-21       Impact factor: 4.677

Review 7.  The Future of Stem Cells and Their Derivates in the Treatment of Glaucoma. A Critical Point of View.

Authors:  Simona Delia Nicoară; Ioana Brie; Ancuța Jurj; Olga Sorițău
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

8.  Chronic retinal detachment and neovascular glaucoma after intravitreal stem cell injection for Usher Syndrome.

Authors:  Kay T Khine; Thomas A Albini; Richard K Lee
Journal:  Am J Ophthalmol Case Rep       Date:  2020-03-07

Review 9.  Outer Retinal Cell Replacement: Putting the Pieces Together.

Authors:  Allison L Ludwig; David M Gamm
Journal:  Transl Vis Sci Technol       Date:  2021-08-12       Impact factor: 3.283

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.